CNBC-TV18's Archana Shukla reports that India's grant of a compulsory licence to Natco for Bayer's kidney-cancer drug Nexavar has sent shockwaves across the globe
first published: Aug 17, 2012 09:54 pm
A collection of the most-viewed Moneycontrol videos.

Live: Nifty sees best single day rally since June 2025, nears record high | Closing Bell

Live: Can Nifty claim new lifetime highs in December series? | Opening Bell

Live: Sensex, Nifty rangebound on monthly expiry day | Closing Bell

Live: Will Nifty's downtrend continue to third session on expiry day? | Opening Bell
You are already a Moneycontrol Pro user.

